Sysmex ADR Inventory 2016-2024 | SSMXY
Sysmex ADR inventory from 2016 to 2024. Inventory can be defined as the total value of inventories in all stages of completion.
- Sysmex ADR inventory for the quarter ending December 31, 2024 was $0.565B, a 13.77% increase year-over-year.
- Sysmex ADR inventory for 2024 was $0.524B, a 3.41% decline from 2023.
- Sysmex ADR inventory for 2023 was $0.542B, a 1.6% decline from 2022.
- Sysmex ADR inventory for 2022 was $0.551B, a 30.24% increase from 2021.
| Sysmex ADR Annual Inventory (Millions of US $) |
|
|---|---|
| 2024 | $524 |
| 2023 | $542 |
| 2022 | $551 |
| 2021 | $423 |
| 2020 | $443 |
| 2019 | $362 |
| 2018 | $387 |
| 2017 | $330 |
| 2016 | $315 |
| Sysmex ADR Quarterly Inventory (Millions of US $) |
|
|---|---|
| 2024-06-30 | $565 |
| 2023-06-30 | $597 |
| 2022-06-30 | $567 |
| 2021-06-30 | $495 |
| 2020-06-30 | $497 |
| 2019-06-30 | $390 |
| 2018-06-30 | $393 |
| 2017-06-30 | $386 |
| 2016-06-30 | $325 |
| 2016-03-31 | $315 |
| 2015-12-31 | |
| 2015-09-30 | |
| 2015-06-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $11.545B | $3.197B |
| Sysmex Corporation is engaged in the development, manufacture, import, export and sale of clinical laboratory instruments, reagents and software used in -vitro diagnostics. It also provides clinical laboratory testing of blood, urine and other specimens. The company's product includes instruments and reagents diagnostics for hemostasis, immunochemistry, clinical chemistry, urinalysis and point-of-care testing. Its operating segment consists of Japan, Americas, EMEA, China and Asia Pacific. Sysmex Corporation is headquartered in Kobe, Japan. | |||